Loading ARQT...
Arcutis Biotherapeutics Inc.ARQTAs of 31 July 2026
Public engagement data
Reactive Search·
Cumulative Search·
Investigative Research·
−300−1500+150+300
9
PositiveNegative
Equilibrium
CheapExpensive
FearGreed
WeakStrong
Emotion

Is Arcutis Biotherapeutics Inc. oversold, or is the crowd euphoric?

A read on the market's emotion around Arcutis Biotherapeutics Inc. (ARQT): where sentiment sits between capitulation and euphoria, measured against the stock's own history so heavily covered and quieter names read on the same scale. Information, not advice.

Arcutis Biotherapeutics Inc.ARQTLast 5 years
VEFA
ARQT priceasymmetryquant.com